AEON Biopharma, Inc.
AEON · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,412 | $8,429 | $2,311 | $21,550 |
| - Cash | $5,927 | $8,439 | $10,446 | $13 |
| + Debt | $18,008 | $16,436 | $14,600 | $12,955 |
| Enterprise Value | $21,493 | $16,426 | $6,465 | $34,492 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,511 | -$4,302 | -$3,931 | -$5,643 |
| % Margin | – | – | – | – |
| Net Income | -$4,538 | -$6,642 | $9,095 | $2,082 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.39 | -0.6 | 2.28 | 3.47 |
| % Growth | 35% | -126.3% | -34.3% | – |
| Operating Cash Flow | -$2,596 | -$2,091 | -$7,909 | -$621 |
| Capital Expenditures | $0 | $0 | -$4 | $0 |
| Free Cash Flow | -$2,596 | -$2,091 | -$7,913 | -$621 |